GAMMA Investing’s MEDIROM Healthcare Technologies MRM Stock Holding History

GAMMA Investing’s Portfolio MRM Stock Details MRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11	Sell	17 -3,781	-100%	-$3.5K	﹤0.01%	4322
2026 Q2	$3.91K	Sell	3,798 -2,611	-41%	-$2.93K	﹤0.01%	3576
2026 Q1	$7.18K	Sell	6,409 -4,146	-39%	-$6.02K	﹤0.01%	3223
2025 Q4	$20.5K	Buy	10,555 +5,941	+129%	+$12.7K	﹤0.01%	2605
2025 Q3	$9.8K	Buy	4,614 +4,510	+4,337%	+$7.57K	﹤0.01%	2886
2025 Q2	$148	Buy	+104	New	+$115	﹤0.01%	3738
2025 Q1	–	Sell	-4,917	Closed	-$5.06K	–	3853
2024 Q4	$5.06K	Buy	+4,917	New	+$12.2K	﹤0.01%	2916

GAMMA Investing's MRM Position: Q3 2026 in Review

GAMMA Investing reduced its MEDIROM Healthcare Technologies (MRM) stake by 100% in Q3 2026, selling an estimated $3.5K and leaving 17 shares worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #4322.

GAMMA Investing first reported a position in MRM in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.5K in Q4 2025. 1 fund tracked by Wall St. Rank holds MRM as of Q3 2026.

GAMMA Investing held 17 shares of MEDIROM Healthcare Technologies worth $11 as of Q3 2026.
GAMMA Investing sold 3,781 MEDIROM Healthcare Technologies shares in Q3 2026, an estimated $3.5K.
MEDIROM Healthcare Technologies made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4322 holding.
GAMMA Investing first reported a position in MEDIROM Healthcare Technologies in Q4 2024 and has held it in 7 quarters since.
GAMMA Investing's MEDIROM Healthcare Technologies position peaked at $20.5K in Q4 2025.
1 fund tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.